CSOP Hang Seng TECH Daily (2x) Leveraged Product (07226.HK) rose 2.88% to HK$2.216; SK hynix Q3 operating profit jumped over sevenfold to KRW83.33 trillion.
SHOUGANG LANZA (02553.HK) closed at HKD 11.49 on October 27, 2026, down 2.63% for the day. The company's shares were included in the Hang Seng Composite Index on September 7, 2026 and were accordingly added to Stock Connect.
E Fund (Hk) Ftse Ai Select Index Etf (03489.HK) rose 4.59% to HKD 11.63 on 28 October as Anthropic filed for what may be the largest IPO ever.
Oct 20: DIAGENS-B granted 778,962 options and RSUs to 23 employees under its 2026 incentive scheme, options at HK$230.44. Added to Stock Connect Sep 7, southbound holdings rose from 0.17% to 0.52%.
YSB (09885.HK) traded at HKD 3.510 on Oct 28, up 2.33%; MIYT Holdings, controlled by founder Zhang Buzhen's trust, holds 18.35%; interim revenue rose 4.5%.
On October 28, 2026, BIDU-W (09888.HK) edged higher. As of 14:18, it was quoted at HK$77.10, up 2.46%.
CSTONE PHARMA-B (02616.HK) traded at HKD 4.820 intraday on Oct 28, up 5.47%, down 20.6% since joining Stock Connect on Sept 7; interim revenue rose 314.8%.
ASMPT (00522.HK) fell 1.57% to HKD 119.300; third-quarter revenue rose 48.7%, and record bookings of HKD 8.845 billion lifted the book-to-bill ratio to 1.69.
XIAOMI-W (01810.HK) fell 0.08% to HKD 25.640; INFIFORCE raised nearly RMB 100 million, and XPENG's robot solid-state battery entered small-batch output.
At 9:58 on Oct 28, 2026, Csop Hang Seng Tech Index Etf (03033.HK) rose 1.18% to HK$3.766, turnover HK$1.38 billion, AUM HK$56.5 billion, NAV HK$3.7255.
At 9:55 on Oct 28, 2026, Chinaamc Hang Seng Hong Kong Biotech Index ETF (03069.HK) rose 2.70% to HK$14.450, turnover HK$41.29 million, AUM HK$3.12 billion.
At 9:53 on Oct 28, 2026, Csop Ftse Hk-Korea Tech+ Index Etf (03431.HK) rose 3.25% to HK$8.895, turnover HK$6.03 million, AUM HK$987.73 million, NAV HK$8.6643.
On 28 Oct 2026, JIANGSU EXPRESSWAY (00177.HK) said its EGM approved the Sunan Expressway acquisition with 99.97% support and a RMB0.25 interim dividend.
On 27 Oct 2026, ASMPT (00522.HK) posted record Q3 bookings of HK$8.45bn, up 137.9% YoY, and revenue of HK$5.25bn, up 48.7%, with Q4 guidance of US$670-730m.
On 27 Oct 2026, BRAINAURORA-B (06681.HK) won Class II device registration for cognitive assessment software for depression patients.
On 28 Oct 2026, IMMUNOTECH-B (06978.HK) agreed to place up to 123.5m new shares at a minimum HK$0.300 each, a 13.04% discount, to raise at least HK$36.1m net.
